Immune-related response evaluations during immune-checkpoint inhibitor therapy: establishing a "common language" for the new arena of cancer treatment.
作者： Mizuki Nishino
DOI: 10.1186/S40425-016-0134-0
关键词: Clinical Oncology 、 Psychotherapist 、 Immune checkpoint inhibitors 、 Response criteria 、 Cancer treatment 、 MEDLINE 、 Unmet needs 、 Immune system 、 Tumor response 、 Medicine
摘要: The recent study by Hodi et al. published in the Journal of Clinical Oncology has evaluated unconventional response patterns during PD-1 inhibitor therapy using immune-related criteria (irRC) comparison with RECIST1.1, which constitutes an important step to further understand phenomena. This commentary discusses key observations terms their implications and pitfalls, describes unmet needs that remain be addressed. article also emphasizes role tumor as a “common language” describe results cancer treatment, future directions for advances field immuno-oncology.
biomedcentral.com
springer.com
paperity.org
core.ac.uk 参考文章(22)
Mizuki Nishino, Suzanne E. Dahlberg, Stephanie Cardarella, David M. Jackman, Michael S. Rabin, Nikhil H. Ramaiya, Hiroto Hatabu, Pasi A. Jänne, Bruce E. Johnson, Volumetric tumor growth in advanced non‐small cell lung cancer patients with EGFR mutations during EGFR‐tyrosine kinase inhibitor therapy Cancer. ,vol. 119, pp. 3761- 3768 ,(2013) , 10.1002/CNCR.28290
Mizuki Nishino, Mengye Guo, David M. Jackman, Pamela J. DiPiro, Jeffrey T. Yap, Tak K. Ho, Hiroto Hatabu, Pasi A. Jänne, Annick D. Van den Abbeele, Bruce E. Johnson, CT tumor volume measurement in advanced non-small-cell lung cancer: Performance characteristics of an emerging clinical tool. Academic Radiology. ,vol. 18, pp. 54- 62 ,(2011) , 10.1016/J.ACRA.2010.08.021
Mizuki Nishino, Stephanie Cardarella, Suzanne E. Dahlberg, David M. Jackman, Nikhil H. Ramaiya, Hiroto Hatabu, Michael S. Rabin, Pasi A. Jnne, Bruce E. Johnson, Radiographic assessment and therapeutic decisions at RECIST progression in EGFR-mutant NSCLC treated with EGFR tyrosine kinase inhibitors Lung Cancer. ,vol. 79, pp. 283- 288 ,(2013) , 10.1016/J.LUNGCAN.2012.11.007
Rajul K. Jain, J. Jack Lee, Chaan Ng, David Hong, Jing Gong, Aung Naing, Jennifer Wheler, Razelle Kurzrock, Change in Tumor Size by RECIST Correlates Linearly With Overall Survival in Phase I Oncology Studies Journal of Clinical Oncology. ,vol. 30, pp. 2684- 2690 ,(2012) , 10.1200/JCO.2011.36.4752
Yusuf Kayar, Nuket Bayram Kayar, Tumor flare reaction in a patient with mantle cell lymphoma Blood Research. ,vol. 49, pp. 279- 280 ,(2014) , 10.5045/BR.2014.49.4.279
E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) European Journal of Cancer. ,vol. 45, pp. 228- 247 ,(2009) , 10.1016/J.EJCA.2008.10.026
Mizuki Nishino, Jyothi P. Jagannathan, Katherine M. Krajewski, Kevin O’Regan, Hiroto Hatabu, Geoffrey Shapiro, Nikhil H. Ramaiya, Personalized tumor response assessment in the era of molecular medicine: cancer-specific and therapy-specific response criteria to complement pitfalls of RECIST. American Journal of Roentgenology. ,vol. 198, pp. 737- 745 ,(2012) , 10.2214/AJR.11.7483
Jeremy J. Erasmus, Gregory W. Gladish, Lyle Broemeling, Bradley S. Sabloff, Mylene T. Truong, Roy S. Herbst, Reginald F. Munden, Interobserver and Intraobserver Variability in Measurement of Non–Small-Cell Carcinoma Lung Lesions: Implications for Assessment of Tumor Response Journal of Clinical Oncology. ,vol. 21, pp. 2574- 2582 ,(2003) , 10.1200/JCO.2003.01.144
J. D. Wolchok, A. Hoos, S. O'Day, J. S. Weber, O. Hamid, C. Lebbe, M. Maio, M. Binder, O. Bohnsack, G. Nichol, R. Humphrey, F. S. Hodi, Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria Clinical Cancer Research. ,vol. 15, pp. 7412- 7420 ,(2009) , 10.1158/1078-0432.CCR-09-1624
Victoria L. Chiou, Mauricio Burotto, Pseudoprogression and Immune-Related Response in Solid Tumors Journal of Clinical Oncology. ,vol. 33, pp. 3541- 3543 ,(2015) , 10.1200/JCO.2015.61.6870